← All trials
NCT07113587
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 8, 2014
- Primary completion
- Jul 7, 2017
- Completion date
- Jul 7, 2017
- First posted
- Aug 11, 2025
- Last posted
- Aug 14, 2025
- Enrollment
- 24
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Karl Landsteiner Insitute for Nephrology and Haemato-OncologyLead sponsor
- University of ViennaCollaborator
- Karl Landsteiner Private University of Health SciencesCollaborator
- Medical University of CologneCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.